close icon

Humana Stock Bulls Haven’t Lost the Battle Yet

Humana (NYSE:HUM) climbed to an all-time high of $356 in early November 2018, following a rally from as low as $18.57 in March 2009. In less than ten years, the company rewarded the patience of its investors with a total return of over 1820%, not counting dividends.

Unfortunately, the last six months were nothing like the past ten years. In mid-April, Humana dived below $223, down over 37% from its peak. Now, if this is the start of a bigger selloff, then it is time to stay aside. But could it actually be a buy-the-dip opportunity?

Humana stock

The weekly chart above allows us to put Humana’s entire progress since the year 2000 into Elliott Wave context. The Financial Crisis of 2008-2009 is labeled as wave II. The phenomenal uptrend to $356 is a textbook five-wave impulse in wave III.

Humana Bulls Aiming at $400 a Share Before Giving Up

This brings us to the present and the recent pullback, which fits in the position of wave IV. It has already touched the 38.2% Fibonacci level, where fourth waves often terminate. The missing piece of the puzzle is wave V. Provided it’s not a truncation, the fifth wave is supposed to exceed the top of wave III. In terms of price, wave V’s initial targets lie near $360 a share, but $400 is quite reasonable as well.

On the other hand, the bulls should tread very carefully. According to the theory, a three-wave correction in the opposite direction follows every impulse. Investors hoping that the 2019 dip is going to fuel a rally similar to the one that followed the dip in 2009 are up for a disappointment.

If this count is correct, Humana is still in an uptrend and aiming at a new all-time high. However, a bearish reversal near the $400 mark can open the door for a ~50% plunge towards the support near $200 a share.

Did you like this analysis? Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

DraftKings on the Verge of Another 40% Decline

It’s been almost three and a half months since we examined DraftKings stock in October, 2020. The share price was hovering near $57 after a strong run from $10.60 to over $64 in just several months. The regulatory environment in the U.S. seemed to be warming up and many analysts hurried to issue their BUY…

Read More »

AMN Healthcare Stock to Suffer a 2020-Like Drop

AMN Healthcare Services provides workforce and staffing solutions to healthcare facilities in the U.S. The company is relatively small with a market capitalization of less than $4 billion. However, small companies can make for excellent returns if one happens to identify the winners. And indeed, between late-2011 and early-2020, AMN stock from under $4 to…

Read More »

Zoetis Stock Getting Ahead of Itself, Invites Correction

Based in Parsippany, NJ, Zoetis Inc. is an animal medicine and vaccine developer and manufacturer. The company went public in 2013 and has been enjoying steady growth since. With the stock currently above $160 a share, Zoetis holds a market cap of nearly $80 billion. For a profitable and growing company like Zoetis, a rising…

Read More »

CBOE Stock Looking Good After a Record Year

CBOE Global Markets Inc. is an equities, options and futures exchange operator in the U.S. and Europe. The company traces its roots back to Chicago in 1973, when it practically invented options trading in its present form. CBOE is literally part of the very infrastructure of modern financial markets. So it is not surprising that…

Read More »

Novo Nordisk Bulls Have an Elliott Wave Problem

Novo Nordisk A/S is a Danish pharmaceuticals major with a market cap of over $160 billion. People need their medication even in recessions, so the company’s business wasn’t as affected by the 2020 crisis as most other industries. Novo Nordisk remains a top-notch pharma with consistent profits and revenue and no debt whatsoever. And the…

Read More »

Lockheed ‘s Correction Still Unfolding as Expected

Almost a year and a half ago, in July 2019, we wrote that Lockheed Martin is likely “setting the stage for an unpleasant surprise.” The stock had just reached a new all-time high and was trading at $370 a share. Optimism was in the air and analysts were more bullish than ever. An indeed, fundamentally,…

Read More »

Campari Bulls to Get a Serious Hangover Soon

Campari is an Italian liquor and spirits maker with traditions dating back to 1860. The company’s stock price plunged sharply in March along with the markets in general and then recovered just as quickly to new records by year-end. As shares hover near all-time highs, however, dark clouds appear to be gathering over the spirits…

Read More »

More analyses